This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Drugmode Aps, Pride Proteomics A/s. Active years: 2008-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2017
Title: Krzysztof Wrzesinski: Innovator in Bioreactor Technology and Diabetes Research
Introduction
Krzysztof Wrzesinski is a notable inventor based in Odense S, Denmark. He has made significant contributions to the fields of bioreactor technology and diabetes research. With a total of 2 patents, his work reflects a commitment to advancing scientific understanding and practical applications in these areas.
Latest Patents
One of his latest patents is a bioreactor with a lid designed for easy access to the incubation cavity. This innovative design allows for the end wall of the incubation cavity to be constituted by the lid, making it fully accessible upon removal. Another significant patent focuses on proteins related to type 2 diabetes. This invention pertains to the use of naturally occurring compounds and their derivatives as markers for predisposition to diabetes-related diseases. It also includes a pharmaceutical composition aimed at treating these diseases.
Career Highlights
Throughout his career, Krzysztof has worked with various companies, including Drugmode Aps and Pride Proteomics A/S. His experience in these organizations has contributed to his expertise and the development of his patented technologies.
Collaborations
Krzysztof has collaborated with notable individuals in his field, including Stephen J Fey and Kurt Højlund. These partnerships have likely enhanced his research and innovation efforts.
Conclusion
Krzysztof Wrzesinski stands out as an inventor whose work in bioreactor technology and diabetes research has the potential to impact both scientific and medical communities. His patents reflect a dedication to innovation and the advancement of health-related technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile